Taitt HE. Global trends and prostate cancer: a review of incidence, detection, and mortality as influenced by race, ethnicity, and geographic location. Am J Mens Health. 2018;12:1807–23. https://doi.org/10.1177/1557988318798279

Article  PubMed  PubMed Central  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. https://doi.org/10.3322/caac.21660

Article  PubMed  Google Scholar 

McGinley KF, Tay KJ, Moul JW. Prostate cancer in men of African origin. Nat Rev Urol. 2016;13:99–107. https://doi.org/10.1038/nrurol.2015.298

Article  CAS  PubMed  Google Scholar 

Rebbeck TR. Prostate cancer disparities by race and ethnicity: from nucleotide to neighborhood. Cold Spring Harb Perspect Med. 2018;8:a030387. https://doi.org/10.1101/cshperspect.a030387

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kunisaki C. Role of the anoctamin family in various carcinomas. Ann Surg Oncol. 2020;27:3112–4. https://doi.org/10.1245/s10434-020-08371-3

Article  PubMed  Google Scholar 

Bera TK, Das S, Maeda H, Beers R, Wolfgang CD, Kumar V, et al. NGEP, a gene encoding a membrane protein detected only in prostate cancer and normal prostate. Proc Natl Acad Sci USA 2004;101:3059–64. https://doi.org/10.1073/pnas.0308746101

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo J, Wang D, Dong Y, Gao X, Tong H, Liu W, et al. ANO7: Insights into topology, function, and potential applications as a biomarker and immunotherapy target. Tissue Cell. 2021;72:101546. https://doi.org/10.1016/j.tice.2021.101546

Article  CAS  PubMed  Google Scholar 

Mohsenzadegan M, Madjd Z, Asgari M, Abolhasani M, Shekarabi M, Taeb J, et al. Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis. Cancer Immunol, Immunother. 2013;62:1609–18. https://doi.org/10.1007/s00262-013-1463-1

Article  CAS  PubMed  Google Scholar 

Marx A, Koopmann L, Höflmayer D, Büscheck F, Hube-Magg C, Steurer S, et al. Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer. Cancer Biol Med. 2021;18:245–55. https://doi.org/10.20892/j.issn.2095-3941.2019.0324

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mohsenzadegan M, Shekarabi M, Madjd Z, Asgari M, Abolhasani M, Tajik N, et al. Study of NGEP expression pattern in cancerous tissues provides novel insights into prognostic marker in prostate cancer. Biomark Med. 2015;9:391–401. https://doi.org/10.2217/bmm.14.106

Article  CAS  PubMed  Google Scholar 

Kaikkonen E, Rantapero T, Zhang Q, Taimen P, Laitinen V, Kallajoki M, et al. ANO7 is associated with aggressive prostate cancer. Int J Cancer. 2018;143:2479–87. https://doi.org/10.1002/ijc.31746

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen F, Madduri RK, Rodriguez AA, Darst BF, Chou A, Sheng X, et al. Evidence of novel susceptibility variants for prostate cancer and a multiancestry polygenic risk score associated with aggressive disease in men of african ancestry. Eur Urol. 2023. https://doi.org/10.1016/J.EURURO.2023.01.022

Conti DV, Darst BF, Moss LC, Saunders EJ, Sheng X, Chou A, et al. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nat Genet. 2021;53:65–75. https://doi.org/10.1038/s41588-020-00748-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaikkonen E, Ettala O, Nikulainen I, Taimen P, Lehtinen I, Boström PJ, et al. ANO7 rs77559646 is associated with first-line docetaxel treatment response in metastatic castration-resistant prostate cancer. Anticancer Res. 2019;39:5353–9. https://doi.org/10.21873/ANTICANRES.13728

Article  CAS  PubMed  Google Scholar 

Yu CC, Chen LC, Huang CY, Lin VC, Lu TL, Lee CH, et al. Genetic association analysis identifies a role for ANO5 in prostate cancer progression. Cancer Med. 2020;9:2372–8. https://doi.org/10.1002/CAM4.2909

Article  CAS  PubMed  PubMed Central  Google Scholar 

Landrum MJ, Lee JM, Benson M, Brown G, Chao C, Chitipiralla S, et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 2016;44:D862–8. https://doi.org/10.1093/nar/gkv1222

Article  CAS  PubMed  Google Scholar 

Jaratlerdsiri W, Jiang J, Gong T, Patrick SM, Willet C, Chew T, et al. African-specific molecular taxonomy of prostate cancer. Nature. 2022;609:552–9. https://doi.org/10.1038/s41586-022-05154-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dayem Ullah AZ, Lemoine NR, Chelala C. SNPnexus: a web server for functional annotation of novel and publicly known genetic variants (2012 update). Nucleic Acids Res. 2012;40:W65–70. https://doi.org/10.1093/nar/gks364

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ng PC. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003;31:3812–4. https://doi.org/10.1093/nar/gkg509

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ramensky V. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 2002;30:3894–900. https://doi.org/10.1093/nar/gkf493

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tamborero D, Rubio-Perez C, Deu-Pons J, Schroeder MP, Vivancos A, Rovira A, et al. Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations. Genome Med. 2018;10:25. https://doi.org/10.1186/s13073-018-0531-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Phan L, Jin Y, Zhang H, Qiang W, Shekhtman E, Shao D. ALFA: allele frequency aggregator. Bethesda, MD: National Center for Biotechnology Information, US National Library of Medicine; 2020.

Stecher G, Tamura K, Kumar S. Molecular evolutionary genetics analysis (MEGA) for macOS. Mol Biol Evol. 2020;37:1237–9. https://doi.org/10.1093/molbev/msz312

Article  CAS  PubMed  PubMed Central  Google Scholar 

Edgar RC. MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinform. 2004;5:113. https://doi.org/10.1186/1471-2105-5-113

Article  CAS  Google Scholar 

Guindon S, Dufayard J-F, Lefort V, Anisimova M, Hordijk W, Gascuel O. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol. 2010;59:307–21. https://doi.org/10.1093/sysbio/syq010

Article  CAS  PubMed  Google Scholar 

Kassambara A. rstatix: Pipe-friendly framework for basic statistical tests. 2021. Available online at: https://rpkgs.datanovia.com/rstatix/

Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–5. https://doi.org/10.1093/bioinformatics/bth457

Article  CAS  PubMed  Google Scholar 

Källberg M, Wang H, Wang S, Peng J, Wang Z, Lu H, et al. Template-based protein structure modeling using the RaptorX web server. Nat Protoc. 2012;7:1511–22. https://doi.org/10.1038/nprot.2012.085

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pravda L, Sehnal D, Toušek D, Navrátilová V, Bazgier V, Berka K, et al. MOLEonline: a web-based tool for analyzing channels, tunnels and pores (2018 update). Nucleic Acids Res. 2018;46:W368–73. https://doi.org/10.1093/nar/gky309

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jaratlerdsiri W, Chan EKF, Gong T, Petersen DC, Kalsbeek AMF, Venter PA, et al. Whole-genome sequencing reveals elevated tumor mutational burden and initiating driver mutations in African men with treatment-naïve, high-risk prostate cancer. Cancer Res. 2018;78:6736–46. https://doi.org/10.1158/0008-5472.CAN-18-0254

Article  CAS  PubMed  Google Scholar 

Dadaev T, Saunders EJ, Newcombe PJ, Anokian E, Leongamornlert DA, Brook MN, et al. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. Nat Commun. 2018;9:2256. https://doi.org/10.1038/s41467-018-04109-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Glaser A, Shi Z, Wei J, Lanman NA, Ladson-Gary S, Vickman RE, et al. Shared inherited genetics of benign prostatic hyperplasia and prostate cancer. Eur Urol Open Sci. 2022;43:54–61. https://doi.org/10.1016/j.euros.2022.07.004

Article  PubMed  PubMed Central  Google Scholar 

Zhang C-H, Wang J-X, Cai M-L, Shao R, Liu H, Zhao W-L. The roles and mechanisms of G3BP1 in tumour promotion. J Drug Target. 2019;27:300–5. https://doi.org/10.1080/1061186X.2018.1523415

Article  CAS  PubMed  Google Scholar 

Wang C, Cui Q, Du R, Liu S, Tian S, Huang H, et al. Expression of G3BP1 in benign and malignant human prostate tissues. Transl Androl Urol. 2021;10:1665–75. https://doi.org/10.21037/tau-20-1450

Article